These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The company has unveiled the results of pirtobrutinib from its BRUIN CLL-313 study
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
Subscribe To Our Newsletter & Stay Updated
